Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type (Nicotine Replacement Therapy (Over-the-Counter and Prescription), Drugs (Varenicline and Zyban), and E-cigarettes (Modular, Disposable, and Rechargeable)), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 17,396.6 million in 2018, and is projected to exhibit a CAGR of 17.8% over the forecast period (2019 - 2027).
Increasing awareness regarding the hazardous effects of smoking and nicotine consumption, awareness programs by various government bodies, and inclusion of novel products such as e-cigarettes and nicotine gum is expected to fuel growth of the smoking cessation and nicotine de-addiction products market over the forecast period. The demand for nicotine de-addiction products is increasing among the addicted smokers, owing to increasing awareness and willingness to quit smoking because of harmful effects of tobacco consumption.
Several manufacturers are focused on launching new products that support addicted smokers to quit smoking. For instance, in August 2017, Cipla Health Limited announced the launch of Nicotex Nicotine Patches. Nicotex Nicotine Patch is a skin/transdermal patch that works on the principle of Nicotine Replacement Therapy (NRT) and helps user to quit smoking in 12 weeks. The patch uses a step-down dosing therapy approach that will help smokers to keep their cravings and withdrawal symptoms in check.
Various governments are taking initiatives to increase awareness among population regarding adverse effects of smoking, which in turn is expected to drive growth of the smoking cessation and nicotine de-addiction products market over the forecast period. For instance, the Ministry of Health and Family Welfare (MoHFW), Government of India in March 2019, National Tobacco Control Program (NTCP) announced that every second Wednesday of March will be observed as ‘No Smoking Day’, annually in India. Furthermore, Government of India launched NTCP in 2008, which adapted the WHO Framework Convention of Tobacco Control (FCTC) and passed the “Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce Production, Supply and Distribution)” Act.
Browse 174 Market Data Tables and 36 Figures spread through 358 Pages and in-depth TOC on "Smoking Cessation and Nicotine De-addiction Products Market, By Product Type (Nicotine Replacement Therapy (Over-the-Counter and Prescription), Drugs (Varenicline and Zyban), and E-cigarettes (Modular, Disposable, and Rechargeable)), by Distribution Channel (Hospitals Pharmacies, Online Pharmacies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"
To know the latest trends and insights related to smoking cessation and nicotine de-addiction products market, click the link below:
Intervention for smoking cessation in global smokers population is an urgent requirement, as the health hazards due to use of tobacco is increasing globally and is especially prevalent in emerging economies. There are different stages of smoking cessation such as pre-contemplation (the initial thought of quitting) and contemplation (when a person decides it is time to quit smoking), and others. Action is required when the attempt is made at least for 24 hours and finally maintenance is when a person is smoke-free for over six months. According to The Indian Journal of Chest Diseases & Allied Sciences, published in 2014, the first-line of treatment part of smoking cessation consists of nicotine replacement therapy, bupropion and varinicline and clonidine and nortriptalin is used as the second-line of treatment.
Key Takeaways of the Smoking Cessation and Nicotine De-addiction Products Market:
- The global smoking cessation and nicotine de-addiction products market is expected to witness a CAGR of 17.8% during the forecast period (2019–2027), owing to research and development of new products and technologies related to nicotine and tobacco cessation. Moreover, increasing awareness about adverse effects of smoking is also expected to favor the smoking cessation and nicotine de-addiction products market growth.
- Among product type, the e-cigarettes segment is expected to account for major revenue share in 2027, owing to increasing adoption of e-cigarettes by college students and other chain smokers in emerging economies. For instance, according to Action in Smoking and Health (ASH) report in 2018, 3.2 million adults in the Great Britain used e-cigarettes in 2018.
- Major players operating in the global smoking cessation and nicotine de-addiction products market include, Pfizer, Inc., GlaxoSmithKline Plc, Johnson & Johnson Limited, Cipla Limited, Perrigo Company Plc, Dr. Reddy’s Laboratories Limited, Imperial Brands Plc, NJOY, Inc., British American Tobacco PLC, and Japan Tobacco Inc.
